Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2022 · 10-Q
Revenue—
Net Income-$4.12M-$4.12MN/M vs Q1 2021 EPS Diluted-$0.19-$0.19N/M vs Q1 2021 Operating Income-$3,926,000N/M Operating Cash Flow-$3,876,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$4,086,000N/M ended Mar 31, 2022 · filed Apr 21, 2022 · 21 d after period end